Tracy Litzi

469 total citations
14 papers, 313 citations indexed

About

Tracy Litzi is a scholar working on Molecular Biology, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Tracy Litzi has authored 14 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Obstetrics and Gynecology and 6 papers in Cancer Research. Recurrent topics in Tracy Litzi's work include Endometrial and Cervical Cancer Treatments (6 papers), Cancer-related molecular mechanisms research (4 papers) and Genetic factors in colorectal cancer (3 papers). Tracy Litzi is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Cancer-related molecular mechanisms research (4 papers) and Genetic factors in colorectal cancer (3 papers). Tracy Litzi collaborates with scholars based in United States and United Kingdom. Tracy Litzi's co-authors include G. Larry Maxwell, Andrew Berchuck, John I. Risinger, Gadisetti V.R. Chandramouli, Thomas P. Conrads, Kathleen M. Darcy, Chad A. Hamilton, Olga Aprelikova, J. Carl Barrett and Nicholas W. Bateman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Cancer Research.

In The Last Decade

Tracy Litzi

14 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracy Litzi United States	10	192	110	64	63	49	14	313
Alex Xiu‐Cheng Fan Switzerland	11	276 1.4×	159 1.4×	33 0.5×	73 1.2×	35 0.7×	16	425
Siv Mjøs Norway	7	142 0.7×	104 0.9×	143 2.2×	93 1.5×	91 1.9×	7	329
Junjie Qu China	11	274 1.4×	200 1.8×	44 0.7×	52 0.8×	27 0.6×	15	371
Laura M S Seeber Netherlands	7	255 1.3×	147 1.3×	62 1.0×	83 1.3×	76 1.6×	7	368
J. Schwarz Germany	7	165 0.9×	71 0.6×	30 0.5×	61 1.0×	50 1.0×	9	308
Stefanie Schrauwen Belgium	7	135 0.7×	80 0.7×	49 0.8×	97 1.5×	32 0.7×	7	267
Shu‐Guang Su China	9	193 1.0×	98 0.9×	32 0.5×	40 0.6×	25 0.5×	13	262
Agnieszka Timorek Poland	9	109 0.6×	55 0.5×	34 0.5×	92 1.5×	122 2.5×	19	258
Tomohiko Tsuruta Japan	5	361 1.9×	336 3.1×	24 0.4×	35 0.6×	25 0.5×	16	448
Gus Rodriguez United States	3	134 0.7×	34 0.3×	64 1.0×	159 2.5×	87 1.8×	3	306

Countries citing papers authored by Tracy Litzi

Since Specialization

Citations

This map shows the geographic impact of Tracy Litzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy Litzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy Litzi more than expected).

Fields of papers citing papers by Tracy Litzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy Litzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy Litzi. The network helps show where Tracy Litzi may publish in the future.

Co-authorship network of co-authors of Tracy Litzi

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy Litzi. A scholar is included among the top collaborators of Tracy Litzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy Litzi. Tracy Litzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kim, Hong Im, Kelly A. Conrads, Brian L. Hood, et al.. (2023). Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment. Gynecologic Oncology. 177. 60–71. 1 indexed citations

Cobb, Lauren, Sharareh Siamakpour‐Reihani, Dadong Zhang, et al.. (2021). Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecologic Oncology. 163(2). 320–326. 10 indexed citations

Teng, Pang-ning, Kelly A. Conrads, Tracy Litzi, et al.. (2021). Integrated multi-omic analyses reveals clinical relevance of endometrial cancer cell line models. Gynecologic Oncology. 162. S11–S11. 1 indexed citations

Teng, Pang-ning, Nicholas W. Bateman, Guisong Wang, et al.. (2017). Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Human Cell. 30(3). 226–236. 7 indexed citations

Bateman, Nicholas W., E.A. Dubil, Guisong Wang, et al.. (2017). Race‐specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer. 123(20). 4004–4012. 20 indexed citations

Phippen, Neil T., Nicholas W. Bateman, Guisong Wang, et al.. (2016). NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer. Frontiers in Oncology. 6. 213–213. 34 indexed citations

Bateman, Nicholas W., E Jaworski, Guisong Wang, et al.. (2015). Elevated AKAP12 in Paclitaxel-Resistant Serous Ovarian Cancer Cells Is Prognostic and Predictive of Poor Survival in Patients. Journal of Proteome Research. 14(4). 1900–1910. 38 indexed citations

Maxwell, G. Larry, Yutaka Shoji, Kathleen M. Darcy, et al.. (2014). MicroRNAs in endometrial cancers from black and white patients. American Journal of Obstetrics and Gynecology. 212(2). 191.e1–191.e10. 29 indexed citations

Risinger, John I., Uma Chandran, Roger Day, et al.. (2013). Gene Expression Analysis of Early Stage Endometrial Cancers Reveals Unique Transcripts Associated with Grade and Histology but Not Depth of Invasion. Frontiers in Oncology. 3. 139–139. 30 indexed citations

10.

Maxwell, G. Larry, Chandramouli Gadisetti, Tracy Litzi, et al.. (2013). Transcript expression in endometrial cancers from Black and White patients. Gynecologic Oncology. 130(1). 169–173. 11 indexed citations

11.

Chandramouli, Gadisetti V.R., Katherine E. Stagliano, Brian L. Hood, et al.. (2012). Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer. SHILAP Revista de lepidopterología. 2. 65–65. 23 indexed citations

12.

Risinger, John I., Gadisetti V.R. Chandramouli, G. Larry Maxwell, et al.. (2007). Global Expression Analysis of Cancer/Testis Genes in Uterine Cancers Reveals a High Incidence of BORIS Expression. Clinical Cancer Research. 13(6). 1713–1719. 59 indexed citations

13.

Risinger, John I., Gadisetti V.R. Chandramouli, G. Larry Maxwell, et al.. (2006). Gene expression analysis of tumor infiltrating lymphocyte markers in endometrial cancers indicates no significant increases in those cases with microsatellite instability. Cancer Biomarkers. 2(1-2). 61–68. 2 indexed citations

14.

Risinger, John I., G. Larry Maxwell, Gadisetti V.R. Chandramouli, et al.. (2005). Gene Expression Profiling of Microsatellite Unstable and Microsatellite Stable Endometrial Cancers Indicates Distinct Pathways of Aberrant Signaling. Cancer Research. 65(12). 5031–5037. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact